Impact of Genotyping P450 2C19 on Hospitalization Period

Pharmacologic Optimization of Voriconazole

NCT00893555 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy

NCT04238884 ·Status: UNKNOWN ·Phase: PHASE4

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

NCT04743544 ·Status: UNKNOWN

Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole

NCT01080651 ·Status: COMPLETED ·Phase: PHASE1

Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism

NCT00175994 ·Status: COMPLETED

A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers

NCT03515382 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)

NCT01782131 ·Status: COMPLETED ·Phase: PHASE3

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

NCT06510699 ·Status: RECRUITING ·Phase: PHASE2

An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients

NCT01321372 ·Status: COMPLETED

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, Food Effects, and Drug-drug Interactions of ACP-196 in Healthy Participants

NCT04901923 ·Status: COMPLETED ·Phase: PHASE1

Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm

NCT06582186 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

NCT04921254 ·Status: UNKNOWN ·Phase: PHASE1

Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations

NCT00673348 ·Status: UNKNOWN

Pharmacokinetics of Voriconazole in Adult ECMO Patients

NCT04868188 ·Status: COMPLETED

Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study

NCT06069505 ·Status: RECRUITING

Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients

NCT01260974 ·Status: UNKNOWN ·Phase: PHASE2

A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants

NCT06677996 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants

NCT06421714 ·Status: COMPLETED ·Phase: PHASE1

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

NCT00548262 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome

NCT00002019 ·Status: COMPLETED ·Phase: NA

Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis

NCT00531479 ·Status: COMPLETED ·Phase: PHASE3

Effect of Multiple Doses of Itraconazole on the Multiple Dose Pharmacokinetics of Lu AE58054 in Healthy Subjects

NCT02122692 ·Status: COMPLETED ·Phase: PHASE1

Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients

NCT05065658 ·Status: COMPLETED

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing

NCT01416025 ·Status: COMPLETED ·Phase: PHASE4

A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults

NCT00855101 ·Status: COMPLETED ·Phase: PHASE1